Literature DB >> 19826753

Validation of the Japanese Osteoporosis Quality of Life Questionnaire.

Keigo Kumamoto1, Toshitaka Nakamura, Takao Suzuki, Itsuo Gorai, Osamu Fujinawa, Hiroaki Ohta, Masataka Shiraki, Kosei Yoh, Saeko Fujiwara, Naoto Endo, Toshio Matsumoto.   

Abstract

The Japanese Society for Bone and Mineral Research developed the Japanese Osteoporosis Quality of Life Questionnaire (JOQOL) to evaluate the disease-specific Health-Related QOL, which is specific for osteoporosis of Japanese patients. JOQOL was revised in 2000; it consisted of 38 items with the scale graded from 0 to 4 and a total full score of 152. To elucidate the reliability and validity of the revised JOQOL, we enrolled 193 postmenopausal women as subjects and diagnosed them as having osteoporosis or osteopenia. The mean age of the subjects was 68.2 +/- 8 years; 58 subjects (30.1%) had at least one vertebral fracture. Among them, 83 patients were retested for reliability. The mean lapse from the time of test to that of retest was 23.7(+/- 9.5) days. The subjects were questioned using the JOQOL, Medical Outcomes Study Short Form 36 (SF-36), along with questions on subjects' characteristics and their ADL. The JOQOL scores at the test and the retest were significantly correlated (r = 0.973) without significant difference between their mean scores. All the JOQOL items showed significant correlations at the test and the retest (Kendall's tau = 0.599-0.947). Cronbach's alpha coefficient of JOQOL was 0.918. These results proved the high reliability of JOQOL. The JOQOL score showed negative correlation with age (r = -0.183). The subjects with vertebral fractures had significantly lower JOQOL scores than the subjects without fractures. The JOQOL showed a significant correlation with all the scores in each domain of eight of SF-36 (r = 0.350-0.839). These results were consistent with that of the preceding study. It is concluded that the reliability and the validity of JOQOL were demonstrated in this study.

Entities:  

Mesh:

Year:  2010        PMID: 19826753     DOI: 10.1007/s00774-009-0125-z

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  19 in total

1.  Diagnostic criteria for primary osteoporosis: year 2000 revision.

Authors:  H Orimo; Y Hayashi; M Fukunaga; T Sone; S Fujiwara; M Shiraki; K Kushida; S Miyamoto; S Soen; J Nishimura; Y Oh-Hashi; T Hosoi; I Gorai; H Tanaka; T Igai; H Kishimoto
Journal:  J Bone Miner Metab       Date:  2001       Impact factor: 2.626

2.  EuroQol--a new facility for the measurement of health-related quality of life.

Authors: 
Journal:  Health Policy       Date:  1990-12       Impact factor: 2.980

Review 3.  Consensus development conference: prophylaxis and treatment of osteoporosis.

Authors: 
Journal:  Am J Med       Date:  1991-01       Impact factor: 4.965

4.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

5.  Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis.

Authors:  P Lips; C Cooper; D Agnusdei; F Caulin; P Egger; O Johnell; J A Kanis; U Liberman; H Minne; J Reeve; J Y Reginster; M C de Vernejoul; I Wiklund
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

6.  Measuring quality of life in women with osteoporosis. Osteoporosis Quality of Life Study Group.

Authors: 
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

7.  Development and validation of a discriminative quality of life questionnaire for osteoporosis (the OPTQoL).

Authors:  E Lydick; S I Zimmerman; B Yawn; B Love; M Kleerekoper; P Ross; A Martin; R Holmes
Journal:  J Bone Miner Res       Date:  1997-03       Impact factor: 6.741

8.  Health-related quality of life (HRQOL) in Japanese osteoporotic patients and its improvement by elcatonin treatment.

Authors:  Kousei Yoh; Kiyoshi Tanaka; Aiko Ishikawa; Tomomi Ishibashi; Yuri Uchino; Yuki Sato; Mari Tobinaga; Naomi Hasegawa; Seiya Kamae; Minako Yoshizawa
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

9.  Back extensor strength and lumbar spinal mobility are predictors of quality of life in patients with postmenopausal osteoporosis.

Authors:  N Miyakoshi; M Hongo; S Maekawa; Y Ishikawa; Y Shimada; E Itoi
Journal:  Osteoporos Int       Date:  2007-04-26       Impact factor: 4.507

Review 10.  Quality of life measurement: bibliographic study of patient assessed health outcome measures.

Authors:  Andrew Garratt; Louise Schmidt; Anne Mackintosh; Ray Fitzpatrick
Journal:  BMJ       Date:  2002-06-15
View more
  10 in total

1.  Effect of resistance exercises on function in older adults with osteoporosis or osteopenia: a systematic review.

Authors:  Mark Wilhelm; Gregory Roskovensky; Karla Emery; Christina Manno; Katherine Valek; Chad Cook
Journal:  Physiother Can       Date:  2012       Impact factor: 1.037

2.  Validation of the Malay version of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) in Malaysia.

Authors:  Thiagarajan Nagammai; Mohamed Mohazmi; Su May Liew; Karuthan Chinna; Pauline Siew Mei Lai
Journal:  Qual Life Res       Date:  2015-02-04       Impact factor: 4.147

3.  Additive effect of elcatonin to risedronate for chronic back pain and quality of life in postmenopausal women with osteoporosis: a randomized controlled trial.

Authors:  Michio Hongo; Naohisa Miyakoshi; Yuji Kasukawa; Yoshinori Ishikawa; Yoichi Shimada
Journal:  J Bone Miner Metab       Date:  2014-08-15       Impact factor: 2.626

4.  Comparison of concurrent treatment with vitamin K2 and risedronate compared with treatment with risedronate alone in patients with osteoporosis: Japanese Osteoporosis Intervention Trial-03.

Authors:  Shiro Tanaka; Teruhiko Miyazaki; Yukari Uemura; Nobuaki Miyakawa; Itsuo Gorai; Toshitaka Nakamura; Masao Fukunaga; Yasuo Ohashi; Hiroaki Ohta; Satoshi Mori; Hiroshi Hagino; Takayuki Hosoi; Toshitsugu Sugimoto; Eiji Itoi; Hajime Orimo; Masataka Shiraki
Journal:  J Bone Miner Metab       Date:  2016-08-02       Impact factor: 2.626

5.  Optimal vitamin D intake for preventing serum 25-hydroxyvitamin D insufficiency in young Japanese women.

Authors:  Hiroaki Ohta; Tatsuhiko Kuroda; Naoko Tsugawa; Yoshiko Onoe; Toshio Okano; Masataka Shiraki
Journal:  J Bone Miner Metab       Date:  2017-11-09       Impact factor: 2.626

6.  Improvement of spinal alignment and quality of life after corrective surgery for spinal kyphosis in patients with osteoporosis: a comparative study with non-operated patients.

Authors:  N Miyakoshi; M Hongo; T Kobayashi; T Abe; E Abe; Y Shimada
Journal:  Osteoporos Int       Date:  2015-05-12       Impact factor: 4.507

7.  Design of a randomized clinical trial of concurrent treatment with vitamin K2 and risedronate compared to risedronate alone in osteoporotic patients: Japanese Osteoporosis Intervention Trial-03 (JOINT-03).

Authors:  Shiro Tanaka; Teruhiko Miyazaki; Yukari Uemura; Tatsuhiko Kuroda; Nobuaki Miyakawa; Toshitaka Nakamura; Masao Fukunaga; Yasuo Ohashi; Hiroaki Ohta; Satoshi Mori; Hiroshi Hagino; Takayuki Hosoi; Toshitsugu Sugimoto; Eiji Itoi; Hajime Orimo; Masataka Shiraki
Journal:  J Bone Miner Metab       Date:  2013-07-05       Impact factor: 2.626

8.  The effects of zoledronic acid treatment on depression and quality of life in women with postmenopausal osteoporosis: A clinical trial study.

Authors:  Feyzi Gokosmanoglu; Ceyhun Varim; Aysegul Atmaca; Mehmet Hulusi Atmaca; Ramis Colak
Journal:  J Res Med Sci       Date:  2016-11-07       Impact factor: 1.852

9.  Responsiveness of the Japanese Osteoporosis Quality of Life questionnaire in women with postmenopausal osteoporosis.

Authors:  Hisashi Urushihara; Kousei Yoh; Etsuro Hamaya; Masanori Taketsuna; Kiyoshi Tanaka
Journal:  Health Qual Life Outcomes       Date:  2014-12-12       Impact factor: 3.186

10.  Clinical efficacy and treatment persistence of monthly minodronate for osteoporotic patients unsatisfied with, and shifted from, daily or weekly bisphosphonates: the BP-MUSASHI study.

Authors:  A Sakai; S Ikeda; N Okimoto; H Matsumoto; K Teshima; Y Okazaki; F Fukuda; S Arita; H Tsurukami; M Nagashima; T Yoshioka
Journal:  Osteoporos Int       Date:  2014-06-05       Impact factor: 4.507

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.